Page last updated: 2024-10-29

iodixanol and Neoplasms

iodixanol has been researched along with Neoplasms in 3 studies

iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"To determine the incidence of post-contrast acute kidney injury (PC-AKI) and presumed contrast-induced acute kidney injury (CI-AKI) following contrast-enhanced CT (CECT) with intravenous application of a reduced dose of the iso-osmolar contrast agent iodixanol in cancer patients with chronic kidney disease."7.96Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol. ( Bez, C; Hinterleitner, C; Horger, M; Werner, S, 2020)
"To determine the incidence of post-contrast acute kidney injury (PC-AKI) and presumed contrast-induced acute kidney injury (CI-AKI) following contrast-enhanced CT (CECT) with intravenous application of a reduced dose of the iso-osmolar contrast agent iodixanol in cancer patients with chronic kidney disease."3.96Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol. ( Bez, C; Hinterleitner, C; Horger, M; Werner, S, 2020)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Werner, S1
Bez, C1
Hinterleitner, C1
Horger, M1
Terrenato, I1
Sperati, F1
Musicco, F1
Pozzi, AF1
di Turi, A1
Caterino, M1
de Lutio di Castelguidone, E1
Setola, SV1
Bellomi, M1
Neumaier, CE1
Conti, L1
Cigliana, G1
Merola, R1
Antenucci, A1
Orlandi, G1
Giordano, A1
Barba, M1
Canitano, S1
Xu, H1
Ohulchanskyy, TY1
Yakovliev, A1
Zinyuk, R1
Song, J1
Liu, L1
Qu, J1
Yuan, Z1

Trials

1 trial available for iodixanol and Neoplasms

ArticleYear
Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
    Journal of cellular physiology, 2018, Volume: 233, Issue:3

    Topics: Adolescent; Adult; Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Iohexol; Italy;

2018

Other Studies

2 other studies available for iodixanol and Neoplasms

ArticleYear
Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
    PloS one, 2020, Volume: 15, Issue:5

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Incidence; Male

2020
Nanoliposomes Co-Encapsulating CT Imaging Contrast Agent and Photosensitizer for Enhanced, Imaging Guided Photodynamic Therapy of Cancer.
    Theranostics, 2019, Volume: 9, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Survival; Contrast Media; Liposomes; Mice, Inbred BALB C; Mice, Nude

2019